Skip to content

The effect of Shengmai Powder on TCM syndrome scores and glucose and lipid metabolism in patients with diabetes and angina pectoris of qi and yin deficiency type

Clinical Observation on the Efficacy of Danhu Tongbi Decoction Combined with Acupoint Plaster Application for Treating Angina Pectoris in Type 2 Diabetes with Coronary Heart Disease (Qi and Yin Deficiency with Heart Meridian Blood Stasis Pattern)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2026001290
Enrollment
Unknown
Registered
2026-05-26
Start date
2022-01-01
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Qi and Yin Deficiency Pattern of Diabetic Angina Pectoris

Interventions

Control group:Implement conventional Western medical treatment
Research Group:Treatment with Shengmai San in combination with the control group

Sponsors

Wenling Traditional Chinese Medicine Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 75 Years

Inclusion criteria

Inclusion criteria: Inclusion Criteria: 1) Meets the diagnostic criteria for diabetes in the "Guidelines for the Diagnosis and Treatment of Type 2 Diabetes Mellitus with Integrated Chinese and Western Medicine," Canadian Cardiovascular Society (CCS) Grade I-III exertional angina, and Chinese medicine pattern identification consistent with the "Chinese Medicine Standards for the Prevention and Treatment of Diabetes" pattern of Qi and Yin Deficiency: Fatigue and lassitude, thirst with frequent drinking, palpitations and shortness of breath, poor appetite, abdominal distension with loose stools, afternoon tidal fever, night sweats, thin and pale tongue body, scanty and dry coating, red or pale red tongue body, deep and fine pulse with weak force; 2) Age 40–75 years; 3) Angina attacks =2 times/week.

Exclusion criteria

Exclusion criteria: Exclusion Criteria: 1) Individuals with contraindications to cupping therapy, such as coagulation disorders or skin lesions; 2) Individuals with allergies to any component of the study drug; 3) Individuals who have participated in other clinical trials within the past month.

Design outcomes

Primary

MeasureTime frame
Lipid Metabolism Indicators;Traditional Chinese Medicine Syndrome Scoring;Cardiac function indicators;Glucose Metabolism Indicators;Incidence of adverse reactions;

Countries

China

Contacts

Public ContactChen Yan

Wenling Traditional Chinese Medicine Hospital

15905862359@163.com15905862359

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Jun 11, 2026